CLINICAL_TRIALS
withdrawal
· 2023-03-15
Clinical Trial Update: Neural Mechanism of Aldosterone-induced Insulin Resistance [Phase 4]
Summary
A Phase 4 clinical trial investigating neural mechanisms of aldosterone-induced insulin resistance has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Wanpen Vongpatanasin | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN